SCHEMBL14698143

SCHEMBL14698143

CC(C)[Si](OCc1ccc(NCC(C)(C)O)c([N+](=O)[O-])c1)(C(C)C)C(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ PKM P14618 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.38
▸ MAPT P10636 6/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ HCAR3 P49019 3/20 0.38
▸ MAPK1 P28482 1/20 0.37
▸ PDCD1 Q15116 1/20 0.37
▸ CD274 Q9NZQ7 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ STAT3 P40763 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14698123 0.80 PARP1 (0.32) ALDH1A1MAPTKDM4EHTTGAA
SCHEMBL30163629 0.79 BCL2 (0.44) KAT2BMEN1KMT2AALDH1A1MAPT
SCHEMBL29154963 0.79 KAT2B (0.58) KAT2BPKMALDH1A1MAPTHCAR3
SCHEMBL29154949 0.77 PRSS1 (0.48) KAT2BKMT2APKMALDH1A1MAPT
SCHEMBL22725480 0.76 HCAR3 (0.44) KAT2BMEN1KMT2APKMALDH1A1
SCHEMBL14698055 0.75 ALDH1A1 (0.44) MEN1KMT2APKMALDH1A1MAPT
SCHEMBL22725406 0.75 KAT2B (0.58) KAT2BALDH1A1MAPTTDP1L3MBTL1
SCHEMBL22725438 0.75 KAT2B (0.43) KAT2BPKMALDH1A1MAPTTDP1
SCHEMBL6261849 0.74 MAPT (0.46) MEN1KMT2APKMALDH1A1MAPT
SCHEMBL22725430 0.74 MAPT (0.61) MEN1KMT2APKMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013024427-A1 NOVEL UREA DERIVATIVES AS TEC KINASE INHIBITORS AND USES THEREOF GLENMARK PHARMACEUTICALS S.A. (CH) 2013-02-21 — — WO disclosed
Send feedback